Total Payments
$140,253
2024 Payments
$9,740
Companies
15
Transactions
421
Medicare Patients
499
Medicare Billing
$102,697
Payment Breakdown by Category
Other$108,585 (77.4%)
Travel$22,239 (15.9%)
Food & Beverage$8,966 (6.4%)
Consulting$425.00 (0.3%)
Education$37.98 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $108,585 | 79 | 77.4% |
| Travel and Lodging | $22,239 | 69 | 15.9% |
| Food and Beverage | $8,966 | 264 | 6.4% |
| Consulting Fee | $425.00 | 3 | 0.3% |
| Education | $37.98 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $89,202 | 220 | $0 (2024) |
| Indivior Inc. | $40,412 | 113 | $0 (2020) |
| ITI, Inc. | $8,661 | 10 | $0 (2022) |
| Shire North American Group Inc | $625.65 | 27 | $0 (2019) |
| Alkermes, Inc. | $605.96 | 18 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $279.68 | 16 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $219.57 | 5 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $56.35 | 3 | $0 (2021) |
| Neos Therapeutics, LP | $49.01 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.94 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,740 | 7 | Janssen Pharmaceuticals, Inc ($9,740) |
| 2023 | $9,714 | 16 | Janssen Pharmaceuticals, Inc ($9,714) |
| 2022 | $7,539 | 11 | ITI, Inc. ($4,491) |
| 2021 | $4,371 | 10 | ITI, Inc. ($3,270) |
| 2020 | $9,202 | 24 | Janssen Pharmaceuticals, Inc ($8,213) |
| 2019 | $29,292 | 122 | Janssen Pharmaceuticals, Inc ($24,748) |
| 2018 | $49,763 | 157 | Indivior Inc. ($36,174) |
| 2017 | $20,632 | 74 | Janssen Pharmaceuticals, Inc ($19,771) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,750.00 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $139.45 | General |
| Category: Neuroscience | ||||||
| 06/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,170.00 | General |
| Category: Neuroscience | ||||||
| 04/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $41.74 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,510.00 | General |
| Category: Neuroscience | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $94.32 | General |
| Category: Neuroscience | ||||||
| 11/21/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Neuroscience | ||||||
| 05/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Neuroscience | ||||||
| 05/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $1.54 | General |
| Category: Neuroscience | ||||||
| 05/11/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,750.00 | General |
| Category: Neuroscience | ||||||
| 05/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $116.87 | General |
| Category: Neuroscience | ||||||
| 05/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $79.80 | General |
| Category: Neuroscience | ||||||
| 05/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $59.93 | General |
| Category: Neuroscience | ||||||
| 05/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $40.97 | General |
| Category: Neuroscience | ||||||
| 05/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $39.91 | General |
| Category: Neuroscience | ||||||
| 05/05/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $430.78 | General |
| Category: Neuroscience | ||||||
| 05/05/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $324.66 | General |
| Category: Neuroscience | ||||||
| 05/05/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $149.93 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,510.00 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $127.90 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $17.03 | General |
| Category: Neuroscience | ||||||
| 03/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Neuroscience | ||||||
| 11/22/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Neuroscience | ||||||
| 10/13/2022 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $960.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 457 | $57,060 | $26,483 |
| 2022 | 3 | 135 | 486 | $45,660 | $24,361 |
| 2021 | 2 | 136 | 454 | $49,330 | $27,413 |
| 2020 | 2 | 150 | 493 | $47,625 | $24,440 |
Total Patients
499
Total Services
1,890
Medicare Billing
$102,697
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 298 | $30,030 | $14,056 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 159 | $27,030 | $12,427 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 395 | $35,550 | $18,944 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 44 | $5,880 | $3,450 | 58.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 47 | $4,230 | $1,967 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 279 | $29,625 | $16,619 | 56.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 60 | 175 | $19,705 | $10,794 | 54.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 68 | 222 | $22,535 | $13,627 | 60.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 271 | $25,090 | $10,813 | 43.1% |
About Dr. Andrew Kwait, MD
Dr. Andrew Kwait, MD is a Psychiatry healthcare provider based in Salem, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700925823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Kwait, MD has received a total of $140,253 in payments from pharmaceutical and medical device companies, with $9,740 received in 2024. These payments were reported across 421 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($108,585).
As a Medicare-enrolled provider, Kwait has provided services to 499 Medicare beneficiaries, totaling 1,890 services with total Medicare billing of $102,697. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Salem, MA
- Active Since 02/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1700925823
Products in Payments
- INVEGA SUSTENNA (Drug) $46,824
- SUBLOCADE (Drug) $38,246
- INVEGA TRINZA (Drug) $25,538
- SPRAVATO (Drug) $16,970
- CAPLYTA (Drug) $8,661
- MYDAYIS (Drug) $396.74
- Aristada 441 mg (Drug) $248.53
- ABILIFY MAINTENA (Drug) $223.29
- TRINTELLIX (Drug) $141.73
- VYVANSE (Drug) $134.12
- LATUDA (Drug) $56.35
- Adzenys XR-ODT (Drug) $49.01
- ARISTADA (Drug) $31.58
- VRAYLAR (Drug) $23.86
- SUBOXONE SUBLINGUAL FILM (Drug) $21.27
- BEXSERO (Biological) $21.06
- AUSTEDO (Drug) $21.03
- NUEDEXTA (Drug) $17.78
- VIVITROL (Drug) $13.00
- Vivitrol (Drug) $12.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Salem
Dr. Teodoro Bordador, Md, MD
Psychiatry — Payments: $29,888
Psychiatry $29,888
Dr. Beal Essink, Md, MD
Psychiatry — Payments: $18,911
Psychiatry $18,911
Alexander Kozlovsky, M.d, M.D
Psychiatry — Payments: $7,577
Psychiatry $7,577
Dr. Abhishek Mehra, Md, MD
Psychiatry — Payments: $4,009
Psychiatry $4,009
Dr. Anjali Varma, M.d, M.D
Psychiatry — Payments: $2,800
Psychiatry $2,800
Dr. Raymond Cavanaugh, M.d, M.D
Psychiatry — Payments: $1,940
Psychiatry $1,940